“As API suppliers, we're a little bit in the center,” Gomes states. “We see what is going on with our shoppers who are generic or branded drug manufacturers, but we also see what is going on on the earliest phase of the availability chain.By the tip of that thirty day period, a major break within the pharmaceutical offer chain appeared immine